Chronic heart failure | New York Heart Association Classification
Item
chronic heart failure (nyha class iii or iv)
boolean
C0264716 (UMLS CUI [1])
C1275491 (UMLS CUI [2])
Maximum oxygen uptake Body Weight
Item
peak oxygen uptake <20 ml/min/kg body weight
boolean
C0429693 (UMLS CUI [1,1])
C0005910 (UMLS CUI [1,2])
Left ventricular ejection fraction
Item
left ventricular ejection fraction <30 %
boolean
C0428772 (UMLS CUI [1])
Diastolic left ventricular diameter end diastolic
Item
left ventricular end-diastolic diameter >55 mm
boolean
C0919652 (UMLS CUI [1,1])
C0442709 (UMLS CUI [1,2])
Pharmaceutical Preparations Stable
Item
stable medication within the last 4 weeks
boolean
C0013227 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
AST/SGOT level raised | ALT (SGPT) level raised | Indication for Liver Dysfunction
Item
elevated got and gpt levels as a sign of hepatic dysfunction
boolean
C0580476 (UMLS CUI [1])
C1443982 (UMLS CUI [2])
C0392360 (UMLS CUI [3,1])
C0086565 (UMLS CUI [3,2])
Creatinine increased | Indication for Renal dysfunction
Item
elevated creatinine levels as a sign of renal dysfunction
boolean
C0151578 (UMLS CUI [1])
C0392360 (UMLS CUI [2,1])
C3279454 (UMLS CUI [2,2])
Diabetes Mellitus, Insulin-Dependent
Item
insulin-dependent diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Hypertensive disease
Item
arterial hypertension
boolean
C0020538 (UMLS CUI [1])
Myopathy | Increased creatine kinase level
Item
muscle disease or elevated ck levels
boolean
C0026848 (UMLS CUI [1])
C2316757 (UMLS CUI [2])
Fibrates
Item
treatment with fibrates
boolean
C1449704 (UMLS CUI [1])
Pharmaceutical Preparations CYP3A4 Metabolized
Item
co-treatment with drugs that are metabolized by cyp3a4
boolean
C0013227 (UMLS CUI [1,1])
C1142644 (UMLS CUI [1,2])
C1524026 (UMLS CUI [1,3])
Disease Study Subject Participation Status Excluded
Item
diseases that disallow a participation in the study
boolean
C0012634 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C2828389 (UMLS CUI [1,3])